Given the high prevalence of PCOS in girls with T2D, using Metformin in this population may have the added benefit of improving the clinical and biochemical features of PCOS in addition to reducing weight, improving insulin sensitivity, and achieving glycemic targets (Table 2). This evidence concerns the gene INS and polycystic ovary syndrome.